Evidence map›Paper›PMID 26164072›Full record

ArticleExperimental eye research2015

In vivo electroretinographic studies of the role of GABAC receptors in retinal signal processing.

Jing Wang, Deb Kumar Mojumder, Jun Yan, An Xie, Robert F Standaert, Haohua Qian, David R Pepperberg, Laura J Frishman

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Synaptotagmin-9 in mouse retina.Visual neuroscience · 2024
    Article
  3. SYNAPTOTAGMIN-9 IN MOUSE RETINA.bioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Jing WangCollege of Optometry, University of Houston, Houston, TX 77204, USA.
Deb Kumar MojumderCollege of Optometry, University of Houston, Houston, TX 77204, USA; Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Jun YanBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Chengdu Kanghong Pharmaceutical Co., Ltd., Sichuan, People's Republic of China.
An XieLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL 60612, USA; Lifespan Cardiovascular Institute and the Warren Alpert School of Medicine of Brown University, Providence, RI 02906, USA.
Robert F StandaertBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Department of Biochemistry and Molecular & Cellular Biology, University of Tennessee, Knoxville, TN 37996, USA.
Haohua QianLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL 60612, USA; National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
David R PepperbergLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL 60612, USA.
Laura J FrishmanCollege of Optometry, University of Houston, Houston, TX 77204, USA.
Oak Ridge National Laboratory · USUniversity of Houston · USBrown University · USNational Institutes of Health · USTexas Tech University · USUniversity of Illinois Chicago · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029879 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAZZONE, THEODORE · 2009 to 2011
$11.0M
Development of Nanoscale Neuromodulating PlatformsR01EY016094 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PEPPERBERG, DAVID R · 2006 to 2010
$6.7M
Evaluation of Visual Function in Animal ModelsZIAEY000530 · NEI · NATIONAL EYE INSTITUTE · PI QIAN, HAOHUA · 2013 to 2025
$1.8M
PROXIMAL RETINAL RESPONSES AND THE ERGR01EY006671 · NEI · UNIVERSITY OF HOUSTON · PI FRISHMAN, LAURA J. · 1986 to 2007
$1.7M
INFANT EYE MOVEMENTS AT ISOLUMINANCEF32EY006671 · NEI · UNIVERSITY OF WASHINGTON · PI LIA, BARRY D · 1995 to 1996
–
NCRR NIH HHS UL1 RR029879NCRR NIH HHS UL1RR029879NEI NIH HHS EY001792NEI NIH HHS EY016094NEI NIH HHS EY06671NEI NIH HHS EY07551NEI NIH HHS F32 EY006671NEI NIH HHS P30 EY001792NEI NIH HHS P30 EY007551NEI NIH HHS R01 EY006671NEI NIH HHS R01 EY016094
6 · The paper itself

Abstract

All three classes of receptors for the inhibitory neurotransmitter GABA (GABAR) are expressed in the retina. This study investigated roles of GABAR, especially GABACR (GABA(A)-ρ), in retinal signaling in vivo by studying effects on the mouse electroretinogram (ERG) of genetic deletion of GABACR versus pharmacological blockade using receptor antagonists. Brief full-field flash ERGs were recorded from anesthetized GABACR(-/-) mice, and WT C57BL/6 (B6) mice, before and after intravitreal injection of GABACR antagonists, TPMPA, 3-APMPA, or the more recently developed 2-AEMP; GABAAR antagonist, SR95531; GABABR antagonist, CGP, and agonist, baclofen. Intravitreal injections of TPMPA and SR95531 were also made in Brown Norway rats. The effect of 2-AEMP on GABA-induced current was tested directly in isolated rat rod bipolar cells, and 2-AEMP was found to preferentially block GABACR in those cells. Maximum amplitudes of dark (DA) and light-adapted (LA) ERG b-waves were reduced in GABACR(-/-) mice, compared to B6 mice, by 30-60%; a-waves were unaltered and oscillatory potential amplitudes were increased. In B6 mice, after injection of TPMPA (also in rats), 3-APMPA or 2-AEMP, ERGs became similar to ERGs of GABACR(-/-) mice. Blockade of GABAARs and GABABRs, or agonism of GABABRs did not alter B6 DA b-wave amplitude. The negative scotopic threshold response (nSTR) was slightly less sensitive in GABACR(-/-) than in B6 mice, and unaltered by 2-AEMP. However, amplitudes of nSTR and photopic negative response (PhNR), both of which originate from inner retina, were enhanced by TPMPA and 3-APMPA, each of which has GABAB agonist properties, and further increased by baclofen. The finding that genetic deletion of GABACR, the GABACR antagonist 2-AEMP, and other antagonists all reduced ERG b-wave amplitude, supports a role for GABACR in determining the maximum response amplitude of bipolar cells contributing to the b-wave. GABACR antagonists differed in their effects on nSTR and PhNR; antagonists with GABAB agonist properties enhanced light-driven responses whereas 2-AEMP did not.

Indexed as

ElectroretinographyGene Expression RegulationAnimalsCells, CulturedDisease Models, AnimalDNAFemaleMaleMiceMice, Inbred C57BLRatsRats, Sprague-DawleyReceptors, GABARetinaRetinal DiseasesDNAGABA-C receptorReceptors, GABAElectroretinogramGABAGABA receptorsRetinaRetinal signaling

Identifiers

PMID26164072
PMCPMC4573340
OpenAlexW1088946249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.